310 related articles for article (PubMed ID: 20362695)
1. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.
Seeff LB; Everson GT; Morgan TR; Curto TM; Lee WM; Ghany MG; Shiffman ML; Fontana RJ; Di Bisceglie AM; Bonkovsky HL; Dienstag JL;
Clin Gastroenterol Hepatol; 2010 Oct; 8(10):877-83. PubMed ID: 20362695
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.
Sanyal AJ; Fontana RJ; Di Bisceglie AM; Everhart JE; Doherty MC; Everson GT; Donovan JA; Malet PF; Mehta S; Sheikh MY; Reid AE; Ghany MG; Gretch DR; Halt-C Trial Group
Gastrointest Endosc; 2006 Dec; 64(6):855-64. PubMed ID: 17140886
[TBL] [Abstract][Full Text] [Related]
3. The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C.
Liu CH; Liang CC; Liu CJ; Hsu SJ; Lin JW; Chen SI; Hung PH; Tsai HB; Lai MY; Chen PJ; Chen JH; Chen DS; Kao JH
Kidney Int; 2010 Jul; 78(1):103-9. PubMed ID: 20357753
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of liver biopsy in chronic hepatitis C.
Strauss E
Ann Hepatol; 2010; 9 Suppl():39-42. PubMed ID: 20713994
[TBL] [Abstract][Full Text] [Related]
5. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
Ghany MG; Lok AS; Everhart JE; Everson GT; Lee WM; Curto TM; Wright EC; Stoddard AM; Sterling RK; Di Bisceglie AM; Bonkovsky HL; Morishima C; Morgan TR; Dienstag JL;
Gastroenterology; 2010 Jan; 138(1):136-46. PubMed ID: 19766643
[TBL] [Abstract][Full Text] [Related]
6. Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis.
Maan R; van der Meer AJ; Hansen BE; Feld JJ; Wedemeyer H; Dufour JF; Zangneh HF; Lammert F; Manns MP; Zeuzem S; Janssen HL; de Knegt RJ; Veldt BJ
J Hepatol; 2014 Sep; 61(3):482-91. PubMed ID: 24780302
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
[TBL] [Abstract][Full Text] [Related]
8. Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
Everson GT; Hoefs JC; Seeff LB; Bonkovsky HL; Naishadham D; Shiffman ML; Kahn JA; Lok AS; Di Bisceglie AM; Lee WM; Dienstag JL; Ghany MG; Morishima C;
Hepatology; 2006 Dec; 44(6):1675-84. PubMed ID: 17133499
[TBL] [Abstract][Full Text] [Related]
9. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C.
Borsoi Viana MS; Takei K; Collarile Yamaguti DC; Guz B; Strauss E
Ann Hepatol; 2009; 8(1):26-31. PubMed ID: 19221530
[TBL] [Abstract][Full Text] [Related]
10. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
11. Aspartate aminotransferase-to-platelet ratio index for fibrosis and cirrhosis prediction in chronic hepatitis C patients.
Silva RG; Fakhouri R; Nascimento TV; Santos IM; Barbosa LM
Braz J Infect Dis; 2008 Feb; 12(1):15-9. PubMed ID: 18553008
[TBL] [Abstract][Full Text] [Related]
12. Low Utility of Screening Hematologic Testing for Image-Guided Biopsies in Patients Without Bleeding Risks.
Matsumoto MM; Altman A; Jothishankar B; Funaki B; Chang PJ
AJR Am J Roentgenol; 2020 Nov; 215(5):1279-1285. PubMed ID: 32901565
[No Abstract] [Full Text] [Related]
13. Liver biopsies for chronic hepatitis C: should nonultrasound-guided biopsies be abandoned?
Flemming JA; Hurlbut DJ; Mussari B; Hookey LC
Can J Gastroenterol; 2009 Jun; 23(6):425-30. PubMed ID: 19543573
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of different noninvasive scores for detecting advanced fibrosis in chronic hepatitis B.
Hamidi AA; Oncul A; Ozguven BY; Sevgi DY; Gunduz A; Uzun N; Dokmetas I
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1439-1443. PubMed ID: 31033847
[TBL] [Abstract][Full Text] [Related]
15. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
16. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
[TBL] [Abstract][Full Text] [Related]
17. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease.
Giannini EG; Greco A; Marenco S; Andorno E; Valente U; Savarino V
Clin Gastroenterol Hepatol; 2010 Oct; 8(10):899-902; quiz e109. PubMed ID: 20601131
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
El-Mezayen HA; Habib S; Marzok HF; Saad MH
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
[TBL] [Abstract][Full Text] [Related]
19. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]